Skip to main content

FDA Approvals

Doptelet (Avatrombopag) Receives FDA Approval for the Treatment of Patients with Chronic Immune Thrombocytopenia

Loretta Fala

Zulresso (Brexanolone) First Drug Approved by the FDA Specifically for Postpartum Depression in Adults

Loretta Fala

FDA Oncology Update

FDA Approvals, In the News

Keytruda Approved for Patients with Previously Treated Metastatic Small-Cell Lung Cancer

FDA Approvals, In the News

First Chemoimmunotherapy Regimen Granted Accelerated Approval for Patients with Previously Treated DLBCL

Tavalisse (Fostamatinib Disodium Hexahydrate) First Spleen Tyrosine Kinase Inhibitor Approved for Chronic Immune Thrombocytopenia

Breast Cancer, FDA Approvals, In the News, Oncology

FDA Expands Indication for Kadcyla to Include the Adjuvant Treatment of HER2-Positive Early Breast Cancer

FDA Approvals, In the News

Tibsovo Now FDA Approved as First-Line Treatment for AML with IDH1 Mutation

Daurismo (Glasdegib) Approved, in Combination with Low-Dose Cytarabine, for Newly Diagnosed Acute Myeloid Leukemia in Older Adults or Those Unfit for Intensive Chemotherapy

Talzenna (Talazoparib) New PARP Inhibitor Approved for the Treatment of HER2-Negative Advanced Breast Cancer with Germline BRCA Mutation

Lisa A. Raedler, PhD, RPh

Page 22 of 53
Results 211 - 220 of 527